Karling Alice Leung

Health Technology

Consumer Services

Profile

Karling Alice Leung served as President & Chief Executive Officer at Intarcia Therapeutics, Inc. from 2004 to 2011.
Prior to that, she held positions as VP-Worldwide Licensing & External Development at Bristol Myers Squibb Co., Principal at Bayer Schering Pharma AG, and Vice President & General Manager at Berlex Pharmaceuticals, Inc. Leung holds an MBA from Cornell University and an undergraduate degree from the University of Western Ontario.

Former positions of Karling Alice Leung

Companies	Position	End
Bayer Schering Pharma AG	Corporate Officer/Principal	-
Berlex Pharmaceuticals, Inc.	Corporate Officer/Principal	-
BRISTOL-MYERS SQUIBB COMPANY	Corporate Officer/Principal	-
Intarcia Therapeutics, Inc. Intarcia Therapeutics, Inc. BiotechnologyHealth Technology Intarcia Therapeutics, Inc. develops therapies for the treatment of chronic diseases. Its lead product candidate, ITCA 650, is currently in development for the treatment of type 2 diabetes. The firm’s platform technology is a proprietary subcutaneous delivery system that involves a matchstick-size, miniature osmotic pump implanted sub-dermally to provide continuous and consistent drug therapy, and the company’s proprietary formulation technology, which maintains stability of therapeutic proteins and peptides at human body temperatures for long extended periods of time. The company was founded by Mark Moran in June 1995 and is headquartered in Boston, MA.	President	-

See the detail of Karling Alice Leung's experience

Training of Karling Alice Leung

Cornell University	Masters Business Admin
University of Western Ontario	Undergraduate Degree

Experiences
Positions held

Active

Inactive

Listed companies

Private companies